Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hamza Irshad"'
Publikováno v:
Pakistan Journal of Medical Research, Vol 60, Iss 1 (2021)
Background: More than 12 million people are suffering from hepatitis infection in Pakistan and most of them are unaware of that. Hepatitis transmission occurs from one person to another through body fluids and can be controlled by risk factor awarene
Externí odkaz:
https://doaj.org/article/b4a49eb9bab248d7b8188e815081e04d
Autor:
null Murtaza Hasnain, null Muhammad Usman, null Sheikh Ishaque Aamir, null Hamza Irshad, null Muhammad Akram
Publikováno v:
The Professional Medical Journal. 29:1838-1845
Objective: To assess the variation of laboratory parameters in COVID-19 positive patients with different genders and age groups and clarify the consequences of COVID-19 infection on different patients. Study Design: Prospective study. Setting: IHITC
Publikováno v:
Journal of Shifa Tameer-e-Millat University. 4:110-116
Introduction: Measles is a highly contagious viral infection, vaccine-preventable diseases claim the lives of nearly 30 million people each year around the world, including 17% of children under the age of 5. Methodology: This was a descriptive and c
BACKGROUND Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) leads to respiratory failure and obstructive alveolar damage, which may be fatal in immunocompromised individuals. COVID-19 pandemic has seve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e60dab899865881888d86dfbacd0426
https://doi.org/10.2196/preprints.41572
https://doi.org/10.2196/preprints.41572
Pangenome analysis of SARS-CoV2 strains to Identify Potential vaccine targets by Reverse Vaccinology
BackgroundCoronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) leads to respiratory failure and obstructive alveolar damage, which may be fatal in immunocompromised individuals. COVID-19 pandemic has sever
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54f5d1d99aedd4c2dd1ad6354b58b779
https://doi.org/10.1101/2022.07.15.500170
https://doi.org/10.1101/2022.07.15.500170
Publikováno v:
International Journal of Infection. 9
Background: The prevalence of hepatitis B in the world differs from low (< 2%) to high (> 8%) in different areas. According to the CDC, more than 320 million people suffer from hepatitis. Viral Hepatitis causes more than one million deaths annually.